J. Goldman & CO LP Revance Therapeutics, Inc. Put Options Transaction History

J. Goldman & CO LP

3 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q1 2023 May 15, 2023	BUY	$18.36 - $35.27 $247,860 - $476,145	13,500 New	13,500 $434,000
Q1 2022 May 16, 2022	SELL	$12.36 - $20.31 $500,580 - $822,555	-40,500 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$12.46 - $27.87 $504,630 - $1.13 Million	40,500 New	40,500 $661,000

196

81.5M

490K

128K

Ticker RVNC
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 82,305,696
Market Cap $212M
Description
Revance Therapeutics, Inc., a biotechnology company, engages in the development, manufacture, and commercialization of neuromodulators for various aesthetic and therapeutic indications in the United States and internationally. The company's lead drug candidate is DaxibotulinumtoxinA for injection, which has completed phase III clinical trials fo...

Get notified when there are updates to the investment portfolio of J. Goldman & CO LP, based on Form 13F filings with the SEC.

Stay updated on J. Goldman & CO LP with notifications on news.